Middletown, DE -- (SBWIRE) -- 08/24/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Cree, Inc.(NASDAQ:CREE), Microchip Technology Inc.(NASDAQ:MCHP), Questcor Pharmaceuticals Inc(NASDAQ:QCOR), Incyte Corporation(NASDAQ:INCY)
Cree, Inc. (NASDAQ:CREE) exchanged 1.95 million shares in the previous trading session, and its average trading remained 2.61 million shares. CREE dropped -0.63% and it closed the trading at $57.00. The market capitalization of the stock remained 6.72 million. YTD trend of the stock was positive +71.69%. Cree, Inc. (Cree) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds. It focuses its expertise in SiC and GaN on light emitting diode (LED) products.
For How Long CREE will fight for Profitability? Read This Trend Analysis report
Microchip Technology Inc.(NASDAQ:MCHP) traded with volume of 1.94 million shares and the average volume of the stock remained 1.71 million shares. The stock grew +0.05% and finished the trading at $39.08. The market capitalization of the stock remained 7.71 billion. The beta of the stock remained 1.05. Microchip Technology Incorporated develops and manufactures specialized semiconductor products used by its customers for a range of embedded control applications. Its product portfolio consists of 8-bit, 16-bit, and 32-bit PIC microcontrollers and 16-bit dsPIC digital signal controllers, which feature on-board Flash (reprogrammable) memory technology.
For How Long MCHP’s Gloss will Attract Investors? Find out via this report
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) enhanced +4.98% and its closing price was $71.84. The volume of the stock was 1.90 million shares and the average volume remained 1.90 million shares. Yesterday, the stock traded amid the day price range of $68.47 - $72.43. The market capitalization of the stock remained 4.31 million. The beta of the stock remained 0.76. Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.
For How Long QCOR will fight for Profitability? Read This Trend Analysis report
Incyte Corporation (NASDAQ:INCY) volume of the stock was 1.86 million shares in the most recent session and the average volume remained 1.76 million shares. The stock boosted +0.29% and finished the prior session at the closing price of $34.76. The stock traded 1.86 million shares in its previous trading session and its average volume remained 1.76 million shares. Incyte Corporation (Incyte) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs. In November 2011, JAKAFI became commercially available in the United States and is being marketed in the United States.
For How Long INCY’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/